Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, 300001, Nigeria.
BMC Complement Altern Med. 2014 Sep 9;14:334. doi: 10.1186/1472-6882-14-334.
Jatropha curcas (JCP1), Pyrenacantha staudtii (PS), Picralima nitida (ZI) and Jatropha gossypifolia (JCP2) are plants used in the African folklore for the treatment of various cancers.
This study investigated the in vitro anticancer effects of the ethanol extracts against human epithelial MCF-7 breast cancer cells in a dose-dependent manner (1-50 μg/ml) by using cell cycle analysis, viability assay, annexin V/PI staining, TUNEL method and expression determination of apoptotic and adhesion relevant proteins. Adhesion processes were monitored by detachment via flow cytometry, β1-integrin expression and formation of the actin cytoskeleton.
The three extracts, termed PS, JCP1 and JCP2 at a concentration of 10 μg/ml induced cell death in MCF-7 breast cancer cells verified by high amounts of PI-positive cells in the cell cycle analysis, Annexin V/PI staining and DNA fragmentation measurements. In parallel cell detachment was accompanied by decreased β1- integrin expression and phosphorylation of the focal adhesion kinase at Tyr397. ZI extract was the exception by the increasing β1-integrin expression and strengthening the cortical actin cytoskeleton. However, all four plant extracts mediated strong anti-cancer properties with IC50 values between 23-38 μg/ml.
PS, JCP1 and JCP2 were found to be very active against MCF-7 cells by inducing anoikis and therefore possessing vast potential as medicinal drugs especially in estrogen receptor positive breast cancer treatment. ZI mediated their anti-cancer action by different signaling mechanisms which should be analyzed in future studies. Our results further supported the idea that medicinal plants can be promising sources of putative anticancer agents.
麻疯树(JCP1)、斜叶榕(PS)、非洲吊灯树(ZI)和黄麻叶麻风树(JCP2)是非洲民间用于治疗各种癌症的植物。
本研究以人上皮 MCF-7 乳腺癌细胞为模型,通过细胞周期分析、细胞活力测定、Annexin V/PI 染色、TUNEL 法以及凋亡和黏附相关蛋白表达的测定,研究了乙醇提取物(浓度为 1-50μg/ml)对 MCF-7 乳腺癌细胞的体外抗癌作用。通过流式细胞术检测细胞脱落、β1-整合素表达和肌动蛋白细胞骨架的形成,监测黏附过程。
三种提取物(PS、JCP1 和 JCP2)在浓度为 10μg/ml 时,通过细胞周期分析、Annexin V/PI 染色和 DNA 片段化测量,证实诱导 MCF-7 乳腺癌细胞死亡,细胞中出现大量的 PI 阳性细胞。同时,细胞脱落伴随着β1-整合素表达减少和粘着斑激酶 Tyr397 磷酸化。ZI 提取物是个例外,表现为β1-整合素表达增加和皮质肌动蛋白细胞骨架增强。然而,四种植物提取物均具有较强的抗癌活性,IC50 值在 23-38μg/ml 之间。
PS、JCP1 和 JCP2 对 MCF-7 细胞具有很强的活性,通过诱导凋亡发挥作用,因此具有作为药物的巨大潜力,特别是在雌激素受体阳性乳腺癌的治疗中。ZI 通过不同的信号转导机制发挥其抗癌作用,这应在未来的研究中进行分析。我们的研究结果进一步支持了药用植物可能是有前途的抗癌药物来源的观点。